HCM - Hutchison China MediTech -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Hutchison China MediTech
Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases.
IPO Date: March 17, 2016
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $2.38B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.44 | 2.05%
Avg Daily Range (30 D): $0.25 | 1.82%
Avg Daily Range (90 D): $0.20 | 1.63%
Institutional Daily Volume
Avg Daily Volume: .16M
Avg Daily Volume (30 D): .07M
Avg Daily Volume (90 D): .06M
Trade Size
Avg Trade Size (Sh.): 89
Avg Trade Size (Sh.) (30 D): 107
Avg Trade Size (Sh.) (90 D): 94
Institutional Trades
Total Institutional Trades: 925
Avg Institutional Trade: $1.84M
Avg Institutional Trade (30 D): $.73M
Avg Institutional Trade (90 D): $.73M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.1M
Avg Closing Trade (30 D): $.63M
Avg Closing Trade (90 D): $.63M
Avg Closing Volume: 88.57K
 
News
Sep 29, 2026 @ 12:00 AM
HUTCHMED Announces Submission of US NDA for ORPATH...
Source: Hutchmed (China) Limited
Sep 28, 2026 @ 12:00 AM
HUTCHMED Initiates Global Trial of KRAS-EGFR-Antib...
Source: Hutchmed (China) Limited
Sep 24, 2026 @ 12:00 AM
HUTCHMED Highlights Clinical Data to be Presented ...
Source: Hutchmed (China) Limited
Sep 2, 2026 @ 1:20 PM
AZN's Tagrisso Plus Orpathys Study in First-Line N...
Source: Na
Aug 31, 2026 @ 12:00 AM
HUTCHMED Announces SANOVO Trial Demonstrated Signi...
Source: Hutchmed (China) Limited
Splits
Apr 20, 2009 1:50